# Aparna Kalyan, M.D. – FDA Inspection, Feb 18, 2025

Source: https://www.keypedia.com/records/fda_inspections/aparna-kalyan-md/da4ea4b9-d098-4973-8880-7c78bb804bf3
Source feed: FDA_Inspections

> FDA inspection 1261875 of Aparna Kalyan, M.D., February 18, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261875
- Company Name: Aparna Kalyan, M.D.
- Inspection Date: 2025-02-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Chicago District Office
- Citation Count: 1

## Related Officers

- [Company Rep](https://www.keypedia.com/people/yuanyuan-li/2043568b-a6ac-4f49-8018-c2c8edda8ac5)

Company: https://www.keypedia.com/companies/aparna-kalyan-md/b13a4163-f370-420a-b036-d98468d3b9b1

Office: https://www.keypedia.com/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669
